Direct Investments & Incentives
Government direct investments, R&D tax credits, and incentive programmes for psychedelic medicine development.
Government Funding Bodies
Compare public funders by role, jurisdiction, source coverage, and whether their grant evidence is linked to recipient-side records or only described in profile programmes.
- Bodies
- 2
- Recipient-linked grants
- 3
- Source links
- 5
- Regional coverage
- 0
Body Types
Jurisdictions
Verification
| Body | Role | Coverage | Evidence | Grant Linkage |
|---|---|---|---|---|
| US Advanced Research Projects Agency for Health (ARPA-H) United States | Public Innovation Agency / Fund Direct Investments & Incentives | National 1 country | Verified3 sources Verified Jul 3, 2026 | Recipient-linked3 linked grants1 profile programs |
| Defense Advanced Research Projects Agency (DARPA) | Defense / Security Research Agency Direct Investments & Incentives | National 1 country | Verified2 sources Verified Apr 11, 2026 | Profile programs1 profile programs |
By country
All Organisations
Defense Advanced Research Projects Agency (DARPA)
US defense research funder with psychedelic-informed neuropsychiatric R&D (Focused Pharma).
US Advanced Research Projects Agency for Health (ARPA-H)
ARPA-H is the US federal agency for high-risk, high-reward biomedical research. Launched the EVIDENT initiative in 2025 (total $139.4M, ≥$50M earmarked for psychedelic research for serious mental illness) to validate and innovate behavioral-health therapeutics including psilocybin and related compounds.